CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 3,150 shares at an average $3.01 ($9,495)
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 3,465 shares (grant or award)
- 4 Shares withheld for taxes Chairman and CEO gave up 37,350 shares (to pay taxes)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 2,560 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and Chief Development Off. gave up 2,870 shares (to pay taxes)
- 4 Other disposition Chief Financial Officer disposed of 7,500 shares (other)
- 4 Open-market buy Sr VP/Chief Commercial Officer bought 12,985 shares at an average $2.81 ($36,505)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- DEF 14A Proxy Proxy Statement
Page 19 of 52 · 1,039 filings